Lebanon National Drugs Database

This section represents the official information about the pharmaceutical products registered & marketed at the Ministry of Public Health

You can search in the form below for information related to drugs including Subsidy percentage

Drugs code ending with "/945" are subject to the Resolution 945/1 date 3/10/2022

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01ED01	XALKORI	B	Crizotinib - 200mg	200mg	Capsule	347,644,061 L.L
L01ED01	XALKORI	B	Crizotinib - 200mg	200mg	Capsule	5,702,209 L.L
B01AF01	XARELTO	B	Rivaroxaban - 20mg	20mg	Tablet, film coated	4,440,862 L.L
B01AF01	XAVIRAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	952,208 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 250IU	250IU	Injectable lyophilised powder for solution+diluent	3,264,169 L.L
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	347,644,061 L.L
L01ED01	XALKORI	B	Crizotinib - 250mg	250mg	Capsule	5,702,209 L.L
L02BB04	XTANDI	B	Enzalutamide - 40mg	40mg	Capsule, soft	4,261,416 L.L
L02BB04	XTANDI	B	Enzalutamide - 40mg	40mg	Capsule, soft	259,803,920 L.L
M03AX01	XEOMIN	BioTech	Clostridium botulinum type A neurotoxin complex - 50 units LD50	50 units LD50	Injectable powder for solution	11,920,109 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	637,349 L.L
B02BD02	XYNTHA	BioTech	Moroctocog alfa - 500IU	500IU	Injectable lyophilised powder for solution+diluent	38,762,207 L.L
L01BC06	XELODA	B	Capecitabine - 500mg	500mg	Tablet, film coated	17,946,398 L.L
S01EE01	XALATAN	B	Latanoprost - 50mcg/ml	50mcg/ml	Drops solution	704,173 L.L
N05AX12	XALIPRO	G	Aripiprazole - 5mg	5mg	Tablet	1,746,995 L.L
R06AE09	XYZAL	B	Levocetirizine dihydrochloride - 5mg	5mg	Tablet, film coated	572,477 L.L
L04AA29	XELJANZ	B	Tofacitinib - 5mg	5mg	Tablet	1,323,438 L.L
L04AA29	XELJANZ	B	Tofacitinib - 5mg	5mg	Tablet	80,685,473 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 75mg	75mg	Injectable solution	7,993,556 L.L
R03DX05	XOLAIR	BioTech	Omalizumab - 75mg	75mg	Injectable solution	19,154,571 L.L